|
Market Closed -
Nasdaq
01:30:00 03/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 52.59 USD | +7.50% |
|
+8.03% | +32.94% |
| 04:48pm | Needham Raises Price Target on AtriCure to $64 From $45, Keeps Buy Rating | MT |
| 26/08 | Atricure Insider Sold Shares Worth $458,099, According to a Recent SEC Filing | MT |
Company Valuation: AtriCure, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 3,194 | 2,064 | 1,692 | 1,490 | 1,967 | 2,488 | - | - |
| Change | - | -35.37% | -18.05% | -11.92% | 32.01% | 26.52% | - | - |
| Enterprise Value (EV) 1 | 3,210 | 2,063 | 1,623 | 1,441 | 1,873 | 2,336 | 2,262 | 2,168 |
| Change | - | -35.73% | -21.32% | -11.21% | 29.97% | 24.75% | -3.18% | -4.18% |
| P/E | 63.8x | -43.5x | -54.1x | -32.2x | -165x | 463x | 117x | 70.4x |
| PBR | 6.61x | 4.52x | 3.55x | 3.24x | 4x | 4.3x | 3.83x | 3.35x |
| PEG | - | 0x | 1.5x | -0.7x | 2.2x | -3x | 0x | 1.1x |
| Capitalization / Revenue | 11.6x | 6.25x | 4.24x | 3.2x | 3.68x | 4.1x | 3.66x | 3.25x |
| EV / Revenue | 11.7x | 6.24x | 4.06x | 3.1x | 3.5x | 3.85x | 3.33x | 2.83x |
| EV / EBITDA | -366x | -943x | 83.5x | 46.3x | 30.3x | 26.7x | 22.2x | 17.5x |
| EV / EBIT | -67.9x | -48.3x | -60.8x | -36x | -198x | 204x | 90.6x | 51x |
| EV / FCF | -136x | -52.9x | -216x | 1,934x | 38.8x | 44x | 56.5x | - |
| FCF Yield | -0.73% | -1.89% | -0.46% | 0.05% | 2.58% | 2.27% | 1.77% | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.09 | -1.02 | -0.66 | -0.95 | -0.24 | 0.1056 | 0.4186 | 0.6946 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 274.3 | 330.4 | 399.2 | 465.3 | 534.5 | 606.2 | 679.6 | 764.6 |
| EBITDA 1 | -8.776 | -2.188 | 19.45 | 31.12 | 61.77 | 87.49 | 101.7 | 124 |
| EBIT 1 | -47.3 | -42.67 | -26.68 | -40.01 | -9.447 | 11.46 | 24.98 | 42.51 |
| Net income 1 | 50.2 | -46.47 | -34.85 | -44.7 | -11.45 | 7.112 | 20.78 | 35.22 |
| Net Debt 1 | 16.09 | -1.265 | -68.63 | -49 | -94.05 | -152.1 | -226.3 | -320.8 |
| Reference price 2 | 69.53 | 44.38 | 35.69 | 30.56 | 39.56 | 48.92 | 48.92 | 48.92 |
| Nbr of stocks (in thousands) | 45,932 | 46,508 | 47,395 | 48,753 | 49,717 | 50,866 | - | - |
| Announcement Date | 15/02/22 | 21/02/23 | 15/02/24 | 12/02/25 | 17/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 463.35x | 3.85x | 26.7x | -.--% | 248.84Cr | |
| 31.25x | 4.22x | 16.23x | 2.36% | 19TCr | |
| 20.48x | 3.6x | 12.83x | 3.13% | 12TCr | |
| 18.12x | 0.21x | 13.2x | 0.72% | 6.32TCr | |
| 30.51x | 7.53x | 19.44x | 1.31% | 5.2TCr | |
| 36.06x | 3.47x | 11.88x | 2.1% | 5.1TCr | |
| 36.13x | 6.36x | 19.96x | -.--% | 3.4TCr | |
| 46.08x | 1.3x | 12.07x | 0.17% | 3.08TCr | |
| 39.49x | 6.91x | 24.81x | 0.27% | 2.38TCr | |
| 19.29x | 3.02x | 10.82x | 1.46% | 2.34TCr | |
| Average | 74.08x | 4.05x | 16.79x | 1.15% | 5.87TCr | |
| Weighted average by Cap. | 30.78x | 3.92x | 15.30x | 1.84% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ATRC Stock
- Valuation AtriCure, Inc.
Select your edition
All financial news and data tailored to specific country editions
